luteusin-C

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameluteusin-C
Drug Alias NameAntibiotic RP 1551-1Antibiotic RP 1551-4Antibiotic RP 1551-M1luteusin-AAntibiotic RP 1551-2 +[9] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kogyo Co Ltd
Active IndicationsN/A
Inactive IndicationsAtherosclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A